Perceptive Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-500,000
| Closed | -$46.5M | – | 159 |
|
|
2021
Q4 | $46.5M | Buy |
+500,000
| New | +$32.9M | 0.72% | 35 |
|
|
2021
Q2 | – | Sell |
-575,007
| Closed | -$39.9M | – | 167 |
|
|
2021
Q1 | $39.9M | Hold |
575,007
| – | – | 0.5% | 51 |
|
|
2020
Q4 | $44.2M | Sell |
575,007
-50,122
| -8% | -$3.76M | 0.47% | 49 |
|
|
2020
Q3 | $46.8M | Sell |
625,129
-470,000
| -43% | -$31.3M | 0.68% | 39 |
|
|
2020
Q2 | $68.9M | Buy |
1,095,129
+420,000
| +62% | +$23.1M | 1.12% | 23 |
|
|
2020
Q1 | $28.4M | Sell |
675,129
-278,000
| -29% | -$12.7M | 0.74% | 35 |
|
|
2019
Q4 | $43.3M | Hold |
953,129
| – | – | 0.86% | 29 |
|
|
2019
Q3 | $43.6M | Sell |
953,129
-427,042
| -31% | -$24M | 1.18% | 24 |
|
|
2019
Q2 | $80.9M | Sell |
1,380,171
-20,000
| -1% | -$1.03M | 1.86% | 13 |
|
|
2019
Q1 | $62.8M | Sell |
1,400,171
-30,000
| -2% | -$1.38M | 1.77% | 16 |
|
|
2018
Q4 | $55.6M | Buy |
1,430,171
+63,193
| +5% | +$2.48M | 2.12% | 11 |
|
|
2018
Q3 | $62.9M | Buy |
1,366,978
+525,000
| +62% | +$21.3M | 1.68% | 18 |
|
|
2018
Q2 | $36.7M | Buy |
841,978
+670,000
| +390% | +$28.8M | 0.96% | 33 |
|
|
2018
Q1 | $6.79M | Buy |
171,978
+150,000
| +683% | +$5.83M | 0.19% | 74 |
|
|
2017
Q4 | $747K | Buy |
+21,978
| New | +$626K | 0.02% | 107 |
|
Perceptive Advisors's ARNA Position: Q1 2022 in Review
Perceptive Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 500,000 shares — an estimated $46.5M sold.
Perceptive Advisors first reported a position in ARNA in Q4 2017 and held it in 15 quarters. The position peaked at $80.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Perceptive Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Perceptive Advisors sold 500,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $46.5M.
- Perceptive Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 15 quarters.
- Perceptive Advisors's Arena Pharmaceuticals Inc position peaked at $80.9M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Perceptive Advisors's 13F filing for Q1 2022, filed 16 May 2022.